Literature DB >> 11888508

Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease.

Christoph Merlo1, Walter A Wuillemin, Maurice Redondo, Miha Furlan, Irmela Sulzer, Johanna Kremer-Hovinga, Bernd R Binder, Bernhard Lämmle.   

Abstract

Increased levels of hemostatic factors may play a role in the pathogenesis of myocardial infarction by triggering thrombin formation. We measured factor XII (FXII), factor XI (FXI), plasma prekallikrein (PK) and high-molecular-weight kininogen (HK) in 200 patients having survived myocardial infarction for at least 2 months, and in 100 healthy controls. We found significantly elevated levels of FXI clotting activity (FXI:C), HK:C and of the amidolytic activity of PK (PK:Am) among the patients as compared to the controls. Plasma levels of FXI:C, HK:C and PK:Am in the highest quartile were associated with an odds ratio of 1.9 (95% CI: 1.0-3.8), 2.0 (95% CI: 1.0-4.0) and 5.4 (95% CI: 2.6-11.2), respectively, compared to the respective plasma levels in the lowest quartile. After correction for established clinical and laboratory risk factors, the association between PK:Am plasma levels and myocardial infarction remained significant (P=0.0007). Combination of high PK:Am plasma levels and smoking or arterial hypertension, respectively, resulted in a more than additive relative risk for myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888508     DOI: 10.1016/s0021-9150(01)00666-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  17 in total

1.  Plasma prekallikrein levels are positively associated with circulating lipid levels and the metabolic syndrome in children.

Authors:  James A MacKenzie; Kristen A Roosa; Brooks B Gump; Amy K Dumas; Kestutis G Bendinskas
Journal:  Appl Physiol Nutr Metab       Date:  2010-08       Impact factor: 2.665

2.  2013 scientific sessions Sol Sherry distinguished lecture in thrombosis: polyphosphate: a novel modulator of hemostasis and thrombosis.

Authors:  Stephanie A Smith; James H Morrissey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-23       Impact factor: 8.311

3.  Novel hemostatic factor levels and risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  M Fareed K Suri; Kazumasa Yamagishi; Nena Aleksic; Peter J Hannan; Aaron R Folsom
Journal:  Cerebrovasc Dis       Date:  2010-03-19       Impact factor: 2.762

4.  Prospective study of plasma high molecular weight kininogen and prekallikrein and incidence of coronary heart disease, ischemic stroke and heart failure.

Authors:  Romil R Parikh; Aaron R Folsom; Jeffrey R Misialek; Wayne D Rosamond; Patricia P Chang; Weihong Tang; Mary Cushman
Journal:  Thromb Res       Date:  2019-08-22       Impact factor: 3.944

5.  Polyphosphate and RNA Differentially Modulate the Contact Pathway of Blood Clotting.

Authors:  Joshua M Gajsiewicz; Stephanie A Smith; James H Morrissey
Journal:  J Biol Chem       Date:  2016-12-22       Impact factor: 5.157

6.  Longitudinal Plasma Kallikrein Levels and Their Association With the Risk of Cardiovascular Disease Outcomes in Type 1 Diabetes in DCCT/EDIC.

Authors:  Miran A Jaffa; Ionut Bebu; Deirdre Luttrell; Barbara H Braffett; John M Lachin; Kelly Hunt; Maria Lopes-Virella; Louis Luttrell; Timothy J Lyons; Ayad A Jaffa
Journal:  Diabetes       Date:  2020-08-21       Impact factor: 9.461

7.  Coagulation factors II, V, IX, X, XI, and XII, plasminogen, and alpha-2 antiplasmin and risk of coronary heart disease.

Authors:  Kazumasa Yamagishi; Nena Aleksic; Peter J Hannan; Aaron R Folsom
Journal:  J Atheroscler Thromb       Date:  2010-04-07       Impact factor: 4.928

8.  Active tissue factor and activated factor XI in circulating blood of patients with systolic heart failure due to ischemic cardiomyopathy.

Authors:  Michał Zabczyk; Saulius Butenas; Ilona Palka; Jadwiga Nessler; Anetta Undas
Journal:  Pol Arch Med Wewn       Date:  2010-09

9.  Plasma Concentrations of High Molecular Weight Kininogen and Prekallikrein and Venous Thromboembolism Incidence in the General Population.

Authors:  Aaron R Folsom; Weihong Tang; Saonli Basu; Jeffrey R Misialek; David Couper; Susan R Heckbert; Mary Cushman
Journal:  Thromb Haemost       Date:  2019-02-19       Impact factor: 5.249

Review 10.  Polyphosphate: a new player in the field of hemostasis.

Authors:  Stephanie A Smith; James H Morrissey
Journal:  Curr Opin Hematol       Date:  2014-09       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.